[1] Aegisdottir AL, Tryggvason G, Jonsdottir AM, et al. Salivary gland tumours in Iceland 1986-2015: a nationwide epidemiological analysis over a 30-year time period [J]. APMIS, 2021, 129(2):55-60. [2] Fu JY, Wu CX, Shen SK, et al. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology [J]. BMC Cancer, 2019, 19(1):350. [3] Pusztaszeri M, Deschler D, Faquin MPW. The 2021 ASCO guideline on the management of salivary gland malignancy endorses FNA biopsy and the risk stratification scheme proposed by the Milan System for Reporting Salivary Gland Cytopathology [J]. Cancer Cytopathol, 2023, 131(2):83-89. [4] Reddy VB, David O, Spitz DJ, et al. Gattuso's differential diagnosis in surgical pathology [M]. Fourth Edition. Philadelphia: Elsevier, 2022:129-217. [5] Wu Y, Lu H, Liu L, et al. Malignant sublingual gland tumors: a single-center retrospective analysis of 79 patients [J]. Oral Dis, 2023. [6] Atallah S, Casiraghi O, Fakhry N, et al. A prospective multicentre REFCOR study of 470 cases of head and neck Adenoid cystic carcinoma: epidemiology and prognostic factors [J]. Eur J Cancer, 2020, 130:241-249. [7] Biondi M, Tettamanti S, Galimberti S, et al. Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the acute myeloid leukemia burden [J]. Blood, 2023, 141(21):2587-2598. [8] Chai H, Qu H, He S, et al. Zedoarondiol inhibits atherosclerosis by regulating monocyte migration and adhesion via CXCL12/CXCR4 pathway [J]. Pharmacol Res, 2022, 182:106328. [9] Wu J, Liu X, Wu J, et al. CXCL12 derived from CD248-expressing cancer-associated fibroblasts mediates M2-polarized macrophages to promote nonsmall cell lung cancer progression [J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(11):166521. [10] Zhang M, Zheng M, Dai L, et al. CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma [J]. J Cell Mol Med, 2021, 25(16):7901-7912. [11] 黄应斌,农晓琳,杨亦萍,等.CXCL12/CXCR4在腺样囊性癌中的表达及对预后的价值[J].实用口腔医学杂志,2015,31(2): 210-214. [12] Uchida D, Kuribayashi N, Kinouchi M, et al. Expression and function of CXCR4 in human salivary gland cancers [J]. Clin Exp Metastasis, 2013, 30(2):133-142. [13] Shi H, Wang J, Dong F, et al. The effect of proteoglycans inhibited by RNA interference on metastatic characters of human salivary adenoid cystic carcinoma [J]. BMC Cancer, 2009, 9:456. [14] Zhang Y, Wang J, Dong F, et al. The effect of proteoglycans inhibited on the neurotropic growth of salivary adenoid cystic carcinoma [J]. J Oral Pathol Med, 2011, 40(6):476-482. [15] Zhang Y, Wang J, Dong F, et al. The role of GPC5 in lung metastasis of salivary adenoid cystic carcinoma [J]. Arch Oral Biol, 2014, 59(11):1172-1182. [16] 张艳宁,石宏,赵增波,等.硫酸乙酰肝素蛋白多糖在唾液腺腺样囊性癌伴神经侵袭中的表达分析[J].现代口腔医学杂志,2021,35(6): 371-375. [17] Chen K, Wang Y, Hou Y, et al. Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer [J]. Cancer Lett, 2022, 545:215834. [18] Yang H, Liu Y, Zhao MM, et al. Therapeutic potential of targeting membrane-spanning proteoglycan SDC4 in hepatocellular carcinoma [J]. Cell Death Dis, 2021, 12(5):492. [19] Zhang MJ, Wang S, Wu CC, et al. Expression of HHLA2, TMIGD2, and GITR in salivary gland adenoid cystic carcinoma and mucoepidermoid carcinoma [J]. J Oral Pathol Med, 2022, 51(4):379-387. [20] Michaelides I, Künzel J, Ettl T, et al. Adenoid cystic carcinoma of the salivary glands: a pilot study of potential therapeutic targets and characterization of the immunological tumor environment and angiogenesis [J]. Eur Arch Otorhinolaryngol, 2023, 280(6):2937-2944. [21] de Sousa LG, Jovanovic K, Ferrarotto R. Metastatic adenoid cystic carcinoma: Genomic landscape and emerging treatments [J]. Curr Treat Options Oncol, 2022, 23(8):1135-1150. [22] Guan H, Tan J, Zhang F, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12 [J]. Histopathology, 2015, 66(6):781-790. [23] Becsky D, Szabo K, Gyulai-Nagy S, et al. Syndecan-4 modulates cell polarity and migration by influencing centrosome positioning and intracellular calcium distribution [J]. Front Cell Dev Biol, 2020, 8:575227. [24] Lambert J, Makin K, Akbareian S, et al. ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis [J]. J Cell Sci, 2020, 133(7):jcs235762. [25] Pessolano E, Belvedere R, Novizio N, et al. Mesoglycan connects Syndecan-4 and VEGFR2 through Annexin A1 and formyl peptide receptors to promote angiogenesis in vitro [J]. FEBS J, 2021, 288(22):6428-6446. [26] Valdivia A, Cárdenas A, Brenet M, et al. Syndecan-4/PAR-3 signaling regulates focal adhesion dynamics in mesenchymal cells [J]. Cell Commun Signal, 2020, 18(1):129. [27] Pham SH, Pratt K, Okolicsanyi RK, et al. Syndecan-1 and-4 influence Wnt signaling and cell migration in human breast cancers [J]. Biochimie, 2022, 198:60-75. [28] Wu Y, Yazdani SK, Bolander J, et al. Syndecan-4 and stromal cell-derived factor-1 alpha functionalized endovascular scaffold facilitates adhesion, spreading and differentiation of endothelial colony forming cells and functions under flow and shear stress conditions [J]. J Biomed Mater Res B Appl Biomater, 2023, 111(3):538-550. [29] Kim S, Han Y, Kim SI, et al. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer [J]. Mol Carcinog, 2021, 60(5):297-312. |